Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Angiopoietin-Like Protein 3 (ANGPTL3) Inhibitors in the Management of Refractory Hypercholesterolemia

Autor: Kosmas,Constantine E, Bousvarou,Maria D, Sourlas,Andreas, Papakonstantinou,Evangelia J, Peña Genao,Edilberto, Echavarria Uceta,Rogers, Guzman,Eliscer

Publikováno v: Clinical Pharmacology: Advances and Applications.

Constantine E Kosmas,1,2 Maria D Bousvarou,3 Andreas Sourlas,3 Evangelia J Papakonstantinou,4 Edilberto Peña Genao,2 Rogers Echavarria Uceta,2 Eliscer Guzman1,2 1Division of Cardiology, Department of Medicine, Montefiore Medical Center, Bronx, NY,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dovemedicalp::463c6880516987f9786bb79d147c2392
https://www.dovepress.com/angiopoietin-like-protein-3-angptl3-inhibitors-in-the-management-of-re-peer-reviewed-fulltext-article-CPAA

Angiopoietin-Like Protein 3 (ANGPTL3) Inhibitors in the Management of Refractory Hypercholesterolemia.

Autor: Kosmas CE; Division of Cardiology, Department of Medicine, Montefiore Medical Center, Bronx, NY, USA.; Cardiology Clinic, Cardiology Unlimited, PC, New York, NY, USA., Bousvarou MD; School of Medicine, University of Crete, Heraklion, Greece., Sourlas A; School of Medicine, University of Crete, Heraklion, Greece., Papakonstantinou EJ; General Directorate of Public Health and Social Welfare, Athens, Attica Region, Greece., Peña Genao E; Cardiology Clinic, Cardiology Unlimited, PC, New York, NY, USA., Echavarria Uceta R; Cardiology Clinic, Cardiology Unlimited, PC, New York, NY, USA., Guzman E; Division of Cardiology, Department of Medicine, Montefiore Medical Center, Bronx, NY, USA.; Cardiology Clinic, Cardiology Unlimited, PC, New York, NY, USA.

Publikováno v: Clinical pharmacology : advances and applications [Clin Pharmacol] 2022 Jul 16; Vol. 14, pp. 49-59. Date of Electronic Publication: 2022 Jul 16 (Print Publication: 2022).

Safety and Tolerability of PCSK9 Inhibitors: Current Insights.

Autor: Kosmas CE; Division of Cardiology, Department of Medicine, Montefiore Medical Center, Bronx, NY, USA., Skavdis A; School of Medicine, University of Athens, Athens, Greece., Sourlas A; School of Medicine, University of Crete, Heraklion, Greece., Papakonstantinou EJ; General Directorate of Public Health and Social Welfare, Attica Region, Athens, Greece., Peña Genao E; Cardiology Clinic, Cardiology Unlimited, PC, New York, NY, USA., Echavarria Uceta R; Cardiology Clinic, Cardiology Unlimited, PC, New York, NY, USA., Guzman E; Division of Cardiology, Department of Medicine, Montefiore Medical Center, Bronx, NY, USA.

Publikováno v: Clinical pharmacology : advances and applications [Clin Pharmacol] 2020 Dec 11; Vol. 12, pp. 191-202. Date of Electronic Publication: 2020 Dec 11 (Print Publication: 2020).